Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ashwini Joshi, Terhi Ollila, Ilkka Immonen & Sangita Kulathinal. (2023) Bayesian Simultaneous Credible Intervals for Effect Measures from Multiple Markers. Statistics in Biopharmaceutical Research 15:3, pages 638-653.
Read now
Read now
Ruben P.A. van Eijk, Adriaan D. de Jongh, Stavros Nikolakopoulos, Christopher J. McDermott, Marinus J.C. Eijkemans, Kit C.B. Roes & Leonard H. van den Berg. (2021) An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 300-307.
Read now
Read now
Articles from other publishers (23)
Ottavia Prunas, Joukje E. Willemsen, Louis Bont, Virginia E. Pitzer, Joshua L. WarrenDaniel M. Weinberger. (2023) Incorporating Data from Multiple Endpoints in the Analysis of Clinical Trials: Example from RSV Vaccines. Epidemiology 35:1, pages 103-112.
Crossref
Crossref
Johan Verbeeck, Maya Dirani, Johann W. Bauer, Ralf-Dieter Hilgers, Geert Molenberghs & Rima Nabbout. (2023) Composite endpoints, including patient reported outcomes, in rare diseases. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Ruth Heller, Abba Krieger & Saharon Rosset. (2022) Optimal multiple testing and design in clinical trials. Biometrics 79:3, pages 1908-1919.
Crossref
Crossref
Adriaan D. de Jongh, Ruben P.A. van Eijk, Leonhard A. Bakker, Tommy M. BunteAnita BeelenConny van der MeijdenMichael A. van EsJohanna M.A. Visser-Meily, Esther T. KruitwagenJan H. Veldink & Leonard H. van den Berg. (2023) Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS. Neurology 101:6.
Crossref
Crossref
Neal O. Jeffries, James F. Troendle & Nancy L. Geller. (2022) Evaluating treatment effects in group sequential multivariate longitudinal studies with covariate adjustment. Biometrics 79:2, pages 1496-1506.
Crossref
Crossref
Yuqian Liu, Shenjie Wang, Yixuan Wang, Yifei Li, Xiaoyan Zhu, Xin Lai, Xuanping Zhang, Xuqi Li, Xiao Xiao & Jiayin Wang. (2023) What makes TMB an ambivalent biomarker for immunotherapy? A subtle mismatch between the sample-based design of variant callers and real clinical cohort. Frontiers in Immunology 14.
Crossref
Crossref
Michael Drummond, Oriana Ciani, Giulia Fornaro, Claudio Jommi, Eva Susanne Dietrich, Jaime Espin, Jean Mossman & Gerard de Pouvourville. (2023) How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?. BMC Health Services Research 23:1.
Crossref
Crossref
Lanwei Guo, Huiyao Huang, Yue Yu, Jun Wang, Le Wang, Shuhang Wang, Dawei Wu, Yuan Fang, Ning Jiang, Shaokai Zhang, Yu Tang & Ning Li. (2023) Outcome measures of phase III anticancer drug trials in China. Chinese Medical Journal 136:8, pages 992-994.
Crossref
Crossref
Glenn-Milo SantosJanet IkedaPhillip CoffinJohn WalkerTim MathesonArsheen AliMatthew McLaughlinJennifer JainJustine ArenanderEric VittinghoffSteven Batki. (2022) Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial. American Journal of Psychiatry 179:12, pages 915-926.
Crossref
Crossref
Yixuan Wang, Xin Lai, Jiayin Wang, Ying Xu, Xuanping Zhang, Xiaoyan Zhu, Yuqian Liu, Yang Shao, Li Zhang & Wenfeng Fang. (2022) TMBcat: A multi-endpoint p-value criterion on different discrepancy metrics for superiorly inferring tumor mutation burden thresholds. Frontiers in Immunology 13.
Crossref
Crossref
Yixuan Wang, Xin Lai, Jiayin Wang, Ying Xu, Xuanping Zhang, Xiaoyan Zhu, Yuqian Liu, Yang Shao, Li Zhang & Wenfeng Fang. (2022) A Joint Model Considering Measurement Errors for Optimally Identifying Tumor Mutation Burden Threshold. Frontiers in Genetics 13.
Crossref
Crossref
Susan E. Waisbren. (2022) Review of neuropsychological outcomes in isolated methylmalonic acidemia: recommendations for assessing impact of treatments. Metabolic Brain Disease 37:5, pages 1317-1335.
Crossref
Crossref
Zhixing Xu & Hui Quan. (2021) Bivariate Bayesian hypothesis testing with missing data in components. Pharmaceutical Statistics 21:2, pages 395-417.
Crossref
Crossref
Nicolas Waespe, Sven Strebel, Tiago Nava, Chakradhara Rao S Uppugunduri, Denis Marino, Veneranda Mattiello, Maria Otth, Fabienne Gumy-Pause, André O Von Bueren, Frederic Baleydier, Luzius Mader, Adrian Spoerri, Claudia E Kuehni & Marc Ansari. (2022) Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol. BMJ Open 12:1, pages e052131.
Crossref
Crossref
Sharon Landesman Ramey, Stephanie C. DeLuca, Richard D. Stevenson, Mark Conaway, Amy R. Darragh & Warren Lo. (2021) Constraint-Induced Movement Therapy for Cerebral Palsy: A Randomized Trial. Pediatrics 148:5.
Crossref
Crossref
Anne-Julie Tessier, Julia Lévy-Ndejuru, Audrey Moyen, Marissa Lawson, Marie Lamarche, Joseé A. Morais, Amritpal Bhullar, Francis Andriamampionona, Vera C. Mazurak & Stéphanie Chevalier. (2021) A 16-week randomized controlled trial of a fish oil and whey protein-derived supplement to improve physical performance in older adults losing autonomy—A pilot study. PLOS ONE 16:8, pages e0256386.
Crossref
Crossref
Stefan K. Plontke. (2021) Seltene Erkrankungen und Hals-Nasen-Ohren-Heilkunde, Kopf und
Halschirurgie. Laryngo-Rhino-Otologie 100:S 01, pages S1-S11.
Crossref
Crossref
Paul W. Thompson. (2020) Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?. Journal of Inherited Metabolic Disease 44:2, pages 301-311.
Crossref
Crossref
Alireza Safa, Allison R. Lau, Sydney Aten, Karl Schilling, Karen L. Bales, Victoria A. Miller, Julie Fitzgerald, Min Chen, Kasey Hill, Kyle Dzwigalski, Karl Obrietan, Mitch A. Phelps, Wolfgang Sadee & John Oberdick. (2021) Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model. Frontiers in Pharmacology 11.
Crossref
Crossref
Christoph Herrmann-Lingen, Christian Albus, Martina de Zwaan, Franziska Geiser, Katrin Heinemann, Martin Hellmich, Matthias Michal, Monika Sadlonova, Ralf Tostmann, Rolf Wachter & Birgit Herbeck Belnap. (2020) Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial. BMC Cardiovascular Disorders 20:1.
Crossref
Crossref
Pavel Mozgunov & Thomas Jaki. (2020) An information theoretic approach for selecting arms in clinical trials. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 82:5, pages 1223-1247.
Crossref
Crossref
Yang Zhao, Qifeng Yu & Stephen L. Lake. (2019) A flexible multi‐domain test with adaptive weights and its application to clinical trials. Pharmaceutical Statistics 19:3, pages 315-325.
Crossref
Crossref
Daniel Li, Craig M. McDonald, Gary L. Elfring, Marcio Souza, Joseph McIntosh, Dae Hyun Kim & Lee-Jen Wei. (2020) Assessment of Treatment Effect With Multiple Outcomes in 2 Clinical Trials of Patients With Duchenne Muscular Dystrophy. JAMA Network Open 3:2, pages e1921306.
Crossref
Crossref